transparent gif


Ej inloggad.

Göteborgs universitets publikationer

A pepducin designed to modulate P2Y2R function interacts with FPR2 in human neutrophils and transfers ATP to an NADPH-oxidase-activating ligand through a receptor cross-talk mechanism.

Författare och institution:
Michael Gabl (Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning); André Holdfeldt (Institutionen för medicin); Malene Winther (Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning); Tudor I Oprea (Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning); Johan Bylund (Institutionen för odontologi, sektion 3); Claes Dahlgren (Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning); Huamei Forsman (Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning)
Publicerad i:
Biochimica et biophysica acta, 1863 ( 6 Pt A ) s. 1228-37
Artikel, refereegranskad vetenskaplig
Sammanfattning (abstract):
Several G-protein-coupled receptors (GPCRs) can be activated or inhibited in a specific manner by membrane-permeable pepducins, which are short palmitoylated peptides with amino acid sequences identical to an intracellular domain of the receptor to be targeted. Unlike the endogenous P2Y2R agonist ATP, the P2Y2PalIC2 pepducin, which has an amino acid sequence corresponding to the second intracellular loop of the human ATP receptor (P2Y2R), activated the superoxide anion-generating NADPH-oxidase in neutrophils. In addition to having a direct effect on neutrophils, the P2Y2R pepducin converted naïve neutrophils to a primed state, which secondarily responded to ATP by producing superoxide. A pepducin with a peptide identical to the third intracellular loop of P2Y2R (P2Y2PalIC3) exhibited the same basic functions as P2Y2PalIC2, whereas one with a peptide that was identical to the first intracellular loop (P2Y2PalIC1) lacked these functions. The responses induced in neutrophils by the P2Y2R pepducins were not inhibited by the P2Y2R antagonist AR-C118925, and the receptor desensitization profile suggested the involvement of FPR2 rather than P2Y2R. Accordingly, antagonists/inhibitors of FPR2 attenuated the activities of the P2Y2R pepducins, which also selectively activated FPR2-overexpressing cells. In summary, we show that pepducins supposed to target P2Y2R activate human neutrophils through FPR2. We also show that the P2Y2PalIC2 pepducin can convert ATP from a non-activating agent to a potent neutrophil NADPH-oxidase activator. The molecular basis of this phenomenon involves cross-talk between the receptor/ligand pairs of P2Y2R/ATP and FPR2/P2Y2-pepducin.
Ämne (baseras på Högskoleverkets indelning av forskningsämnen):
Medicinska grundvetenskaper
Klinisk medicin
Adenosine Triphosphate, metabolism, Amino Acid Sequence, Binding, Competitive, drug effects, Calcium, metabolism, Cells, Cultured, HL-60 Cells, Humans, Ligands, Molecular Sequence Data, NADPH Oxidase, metabolism, Neutrophils, cytology, drug effects, metabolism, Oxygen, metabolism, Peptides, metabolism, pharmacology, Protein Binding, drug effects, Receptor Cross-Talk, drug effects, Receptors, Formyl Peptide, metabolism, Receptors, Lipoxin, metabolism, Receptors, Purinergic P2Y2, chemistry, metabolism, Time Factors
Postens nummer:
Posten skapad:
2016-09-02 16:15

Visa i Endnote-format

Göteborgs universitet • Tel. 031-786 0000
© Göteborgs universitet 2007